Skip to main content

MODIFICACIONES POST-TRASDUCCIONALES EN EL CANCER DE HIGADO

SAF2014-54658-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre ASOCIACION CENTRO DE INVESTIGACION COOP EN BIOCIENCIAS CIC BIOGUNE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Reseña (Review)

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

  • Barbier-Torres, Lucía
  • Iruzubieta, Paula
  • Fernández-Ramos, David
  • Delgado, Teresa C.
  • Taibo, Daniel
  • Gutiérrez de Juan, Virginia
  • Varela‐Rey, Marta
  • Azkargorta, Mikel
  • Navasa Mayo, Nicolás
  • Fernández-Tussy, Pablo
  • Zubiete-Franco, Imanol
  • Simón, Jorge
  • Lopitz-Otsoa, Fernando
  • Lachiondo-Ortega, Sofia
  • Crespo, Javier
  • Masson, Steven
  • McCain, Misti Vanette
  • Villa, Erica
  • Reeves, Helen L.
  • Elortza, Félix
  • Lucena, María Isabel
  • Hernández-Álvarez, Maria Isabel
  • Zorzano, Antonio
  • Andrade, Raúl J.
  • Lu, Shelly C.
  • Mato, José M.
  • Anguita, Juan
  • Rincón, Mercedes
  • Martínez‐Chantar, María Luz
[EN]Acetaminophen (APAP) is the active component of many medications used to treat pain and fever worldwide. Its overuse provokes liver injury and it is the second most common cause of liver failure. Mitochondrial dysfunction contributes to APAP-induced liver injury but the mechanism by which APAP causes hepatocyte toxicity is not completely understood. Therefore, we lack efficient therapeutic strategies to treat this pathology. Here we show that APAP interferes with the formation of mitochondrial respiratory supercomplexes via the mitochondrial negative regulator MCJ, and leads to decreased production of ATP and increased generation of ROS. In vivo treatment with an inhibitor of MCJ expression protects liver from acetaminophen-induced liver injury at a time when N-acetylcysteine, the standard therapy, has no efficacy. We also show elevated levels of MCJ in the liver of patients with acetaminophen overdose. We suggest that MCJ may represent a therapeutic target to prevent and rescue liver injury caused by acetaminophen., SI